These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23785583)

  • 1. Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.
    Govindan S; Kuster DW; Lin B; Kahn DJ; Jeske WP; Walenga JM; Leya F; Hoppensteadt D; Fareed J; Sadayappan S
    Am J Cardiovasc Dis; 2013; 3(2):60-70. PubMed ID: 23785583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.
    Kuster DW; Cardenas-Ospina A; Miller L; Liebetrau C; Troidl C; Nef HM; Möllmann H; Hamm CW; Pieper KS; Mahaffey KW; Kleiman NS; Stuyvers BD; Marian AJ; Sadayappan S
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H547-56. PubMed ID: 24337456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.
    Govindan S; McElligott A; Muthusamy S; Nair N; Barefield D; Martin JL; Gongora E; Greis KD; Luther PK; Winegrad S; Henderson KK; Sadayappan S
    J Mol Cell Cardiol; 2012 Jan; 52(1):154-64. PubMed ID: 21971072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium.
    Lynch TL; Sadayappan S
    Proteomics Clin Appl; 2014 Aug; 8(7-8):569-77. PubMed ID: 24888514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Myosin-Binding Protein C Release Profile After Cardiac Surgery in Intensive Care Unit.
    Chen XJ; Zhang W; Bian ZP; Wang ZM; Zhang J; Wu HF; Shao YF; Zhang JN; Zhao S
    Ann Thorac Surg; 2019 Oct; 108(4):1195-1201. PubMed ID: 31034826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.
    Schulte C; Barwari T; Joshi A; Theofilatos K; Zampetaki A; Barallobre-Barreiro J; Singh B; Sörensen NA; Neumann JT; Zeller T; Westermann D; Blankenberg S; Marber M; Liebetrau C; Mayr M
    Circ Res; 2019 Jul; 125(3):328-340. PubMed ID: 31159652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay.
    Kuster DW; Barefield D; Govindan S; Sadayappan S
    J Vis Exp; 2013 Aug; (78):. PubMed ID: 23963065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Value of Plasma Levels of Cardiac Myosin Binding Protein-C as a Novel Biomarker in Heart Failure.
    El Amrousy D; Hodeib H; Suliman G; Hablas N; Salama ER; Esam A
    Pediatr Cardiol; 2017 Feb; 38(2):418-424. PubMed ID: 27878630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine kinase isoenzyme MB mass, cardiac troponin T, and myosin light chain isotype 1 as serological markers of myocardial injury and their prognostic importance in acute coronary syndrome.
    Ravkilde J
    Dan Med Bull; 1998 Feb; 45(1):34-50. PubMed ID: 9504265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Released Cardiac Myosin Binding Protein-C as a Predictor of Cardiovascular Events.
    Tong CW; Dusio GF; Govindan S; Johnson DW; Kidwell DT; De La Rosa LM; Rosas PC; Liu Y; Ebert E; Newell-Rogers MK; Michel JB; Trzeciakowski JP; Sadayappan S
    Am J Cardiol; 2017 Nov; 120(9):1501-1507. PubMed ID: 28847594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Myosin Binding Protein-C Autoantibodies are Potential Early Indicators of Cardiac Dysfunction and Patient Outcome in Acute Coronary Syndrome.
    Lynch TL; Kuster DWD; Gonzalez B; Balasubramanian N; Nair N; Day S; Calvino JE; Tan Y; Liebetrau C; Troidl C; Hamm CW; Güçlü A; McDonough B; Marian AJ; van der Velden J; Seidman CE; Huggins GS; Sadayappan S
    JACC Basic Transl Sci; 2017 Apr; 2(2):122-131. PubMed ID: 28596995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific phosphorylation of myosin binding protein-C coordinates thin and thick filament activation in cardiac muscle.
    Ponnam S; Sevrieva I; Sun YB; Irving M; Kampourakis T
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15485-15494. PubMed ID: 31308242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes.
    Fesmire FM; Christenson RH; Fody EP; Feintuch TA
    Ann Emerg Med; 2004 Jul; 44(1):12-9. PubMed ID: 15226704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent cardiac troponin-I screening is an effective means of surveillance for a perioperative myocardial infarction.
    Martinez EA; Nass CM; Jermyn RM; Rosenbaum SH; Akhtar S; Chan DW; Malkus H; Weiss JL; Fleisher LA
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):577-82. PubMed ID: 16202889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.
    de Lange WJ; Grimes AC; Hegge LF; Ralphe JC
    J Gen Physiol; 2013 Jan; 141(1):73-84. PubMed ID: 23277475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure.
    El-Armouche A; Pohlmann L; Schlossarek S; Starbatty J; Yeh YH; Nattel S; Dobrev D; Eschenhagen T; Carrier L
    J Mol Cell Cardiol; 2007 Aug; 43(2):223-9. PubMed ID: 17560599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.
    Mamidi R; Gresham KS; Li A; dos Remedios CG; Stelzer JE
    J Mol Cell Cardiol; 2015 Aug; 85():262-72. PubMed ID: 26100051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
    Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
    Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.